Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease. Article

authors

  • Kitano, M
  • Millo, C
  • Rahbari, R
  • Herscovitch, P
  • Gesuwan, K
  • Webb, RC
  • Venkatesan, AM
  • Phan, GQ
  • Hughes, Marybeth S.
  • Libutti, SK
  • Nilubol, N
  • Linehan, WM
  • Kebebew, E

publication date

  • 2011

published in

PubMed Central ID

  • pmc3293369

start page

  • 1122

end page

  • 8

volume

  • 150

issue

  • 6